The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Historical Yearly Usage of Vancomycin
Open accessAbstract
The reasons for the emergence and spread of vancomycin-resistant enterococci are not yet fully understood. Nevertheless, various hypotheses and proposals which are being vigorously and extensively debated have been advanced (1-7, 10, 11, 15, 17, 19). The use of avoparcin, another member of the glycopeptide class of antibiotics, as a growth-promoting agent in the production of food animals is often cited as playing a role in the spread of glycopeptide-resistant microorganisms (1, 18, 20). Although it is well recognized that vancomycin resistance is more prevalent in the United States than in Europe, it has not been explained why avoparcin usage fails to correlate with the different epidemiologies of resistance between the two continents; avoparcin was never approved for use in animals in the United States, in contrast to its broad use as a growth-promoting agent in Europe (5, 7, 10).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Vancomycin-Resistant Enterococcus faecium Bacteremia: Risk Factors for Infection
Edmond, M. B., Ober, J. F., Weinbaum, D. L., Pfaller, M. A., Hwang, T., Sanford, M. D., & Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1126 · Cited by 500
Recommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140952 · Cited by 281
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 279
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.
Keighley, M. R., Burdon, D. W., Arabi, Y., Williams, J. A., Thompson, H., Youngs, D., Johnson, M., Bentley, S., George, R. H., & Mogg, G. A. (1978) · BMJ · doi:10.1136/bmj.2.6153.1667 · Cited by 254
Resistance to Glycopeptides in Enterococci
Leclercq, R., & Courvalin, P. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.545 · Cited by 239
van der Auwera, P., Pensart, N., Korten, V., Murray, B. E., & Leclercq, R. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1129 · Cited by 232
Hospital-acquired infections: diseases with increasingly limited therapies.
Swartz, M. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2420 · Cited by 230
Aarestrup, F. M., Ahrens, P., Madsen, M., Pallesen, L. V., Poulsen, R. L., & Westh, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1938 · Cited by 170
Presence of vancomycin-resistant enterococci in farm and pet animals
Devriese, L. A., Ieven, M. M., Goossens, H., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2285 · Cited by 166
Cited by
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Fiore, E., Van Tyne, D., & Gilmore, M. S. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0053-2018 · Cited by 503
Vancomycin-resistant enterococci: why are they here, and where do they come from?
Bonten, M. J., Willems, R., & Weinstein, R. A. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00145-1 · Cited by 400
Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus
Tenover, F. C., Biddle, J. W., & Lancaster, M. V. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010237 · Cited by 391
Selective pressure by antibiotic use in livestock
Witte, W. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00301-0 · Cited by 315
Metadata
- Authors
- Kirst, H. A., Thompson, D. G., & Nicas, T. I.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-05
- Volume
- 42
- Issue
- 5
- Pages
- 1303-1304
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1924960875
- Cited by
- 276
- References
- 14
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Historical Yearly Usage of Vancomycin. https://app.cochat.ai/papers/10.1128/aac.42.5.1303
- The paper
- Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998). Historical Yearly Usage of Vancomycin. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.42.5.1303
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
